四川精神卫生2024，Vol.37Issue(6)：576-582,7.DOI:10.11886/scjsws20240330002
中国老年人抑郁障碍患病率的Meta分析
Prevalence of depressive disorder among elderly people in China:a Meta-analysis
摘要
Abstract
Background Depressive disorder is one of the most common mental disorders in the elderly and the existing meta-analyses on the prevalence of depressive disorder among the elderly have mainly summarized the findings from patient self-rating scales or examiner-rating scales.Objective To examine the prevalence of depressive disorder among elderly people in China using Meta-analysis,aiming to provide references for interventions targeting elderly patients with depressive disorder.Methods On December 20,2022,a computerized searches were conducted in databases including CNKI,Wanfang,VIP,SinoMed,PubMed,Springer,Web of Science and Embase to collect studies on the prevalence of depressive disorder among the elderly in China.The Joanna Briggs Institute(JBI)quality assessment tool was used to evaluate the included literature.A meta-analysis was conducted using the statistical software R version 4.2.2.Results A total of 29 studies involving 2 341 elderly patients with depressive disorder were included.The prevalence of depressive disorder among the elderly in China was 3.90％(95％CI:0.030～0.049).Subgroup analysis revealed that there was a statistical difference in the prevalence of depressive disorder between elderly people without spouses and those with spouses(χ2=6.844,P<0.01).Conclusion The prevalence of depressive disorder among the elderly in China is relatively high,and the prevalence of depressive disorder among those without a spouse is higher than that of those with a spouse.关键词
抑郁障碍/患病率/老年人/Meta分析Key words
Depressive disorder/Prevalence/The elderly/Meta-analysis分类
医药卫生引用本文复制引用
吴萍,黄光彪,谭忠林,吴月,梁素改..中国老年人抑郁障碍患病率的Meta分析[J].四川精神卫生,2024,37(6):576-582,7.基金项目
杭州市科技发展计划项目(项目名称:红外线全身热疗在抑郁障碍治疗有效性和安全性的随机双盲安慰剂平行对照临床试验研究,项目编号:20201203B192) [Funded by Hangzhou Science and Technology Development Project(number,20201203B192) （项目名称:红外线全身热疗在抑郁障碍治疗有效性和安全性的随机双盲安慰剂平行对照临床试验研究,项目编号:20201203B192）
